R.K. Khosla is a serial technology entrepreneuer. In his role, Khosla has successfully launched ChanRx and is engaged in the development of two other healthcare start-ups. Prior to BioEnterprise, Khosla was CEO of Peritec Biosciences, a Cleveland Clinic medical device spinout. Khosla has a wide background in finance, entrepreneurship and venture capital. Highlights include two years as a Principal concentrating on wireless technologies at Crystal Ventures, a tech venture fund with $240 million under management with offices in Cleveland, Palo Alto, Singapore, and Taipei. He was also CFO and Director of Back Office Operations for All Wound Up which was sold to Borders Group. Khosla started his career at National City in Corporate Banking with the majority of his time being spent in Merchant Banking and Mergers & Acquisitions. Khosla received a B.S. in Electrical Engineering and Applied Physics with an Economics Minor from Case Western Reserve University and his M.B.A. from Yale.